GE Healthcare to Develop Next Generation Compact Cyclotron and PET Tracer System for Global Markets

UPPSALA, Sweden & WAUKESHA, Wis.--(BUSINESS WIRE)--GE Healthcare, a unit of General Electric Company (NYSE: GE), and NXT2B, a privately owned venture capital company, today announced they have entered into a joint financing agreement with the goal of developing a micro-scale radiotracer infrastructure including cyclotron and PET tracer production. The three-year development project will be led by GE Healthcare and will be headquartered in Uppsala, Sweden. The terms of the agreement were not disclosed.
MORE ON THIS TOPIC